Al Bakoush FB,Azab AE,Yahya R .2023 .Neonatal sepsis: insight into incidence, classification, risk factors, causative organisms, pathophysiology, prognosis, clinical manifestations, complications, systemic examination and treatment. South Asian Res. J. App. Med. Sci., 5(6) : 136-157.
Bakhsh A,Moyes D,Proctor G,Mannocci F,Niazi SA .2022 .The impact of apical periodontitis, non-surgical root canal retreatment and periapical surgery on serum inflammatory biomarkers. Int. Endod. J., 55(9) : 923-937.
Beudeker CR,Vijlbrief DC,van Montfrans JM,Rooijakkers SH,Flier MVd SH .2022 .Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies? Front Immunol. , 13 : 1016877.
Boscarino G,Romano R,Iotti C,Tegoni F,Perrone S,Esposito S S .2024 .An overview of antibiotic therapy for early-and late-onset neonatal sepsis: Current strategies and future prospects. Antibiotics, 13(3) : 250.
Celik IH,Hanna M,Canpolat FE,Pammi M .2022 .Diagnosis of neonatal sepsis: The past, present and future. Pediatr. Res., 91(2) : 337-350.
Darlow C A,da Costa R M S,Franceschi F,Sharland M,Piddock L,Das S,Hope W .2021 .Potential antibiotics for the treatment of neonatal sepsis caused by multidrug-resistant bacteria. Pediatr. Drugs, 23 : 465-484.
Dudeja S ,Indian J.,Pediatr J. .2020 .Neonatal sepsis: Treatment of neonatal sepsis in multidrug-resistant (MDR) infections: part 2. , 87(2) : 122-124.
Eichberger J,Resch E,Resch B .2022 .Diagnosis of neonatal sepsis: The role of inflammatory markers. Front. Pediatr, 10 : 840288.
Fleischmann C,Reichert F,Cassini A,Horner R,Harder T,Markwart R,Tröndle M,Savova Y,Kissoon N,Schlattmann P .2021 .Global incidence and mortality of neonatal sepsis: A systematic review and meta-analysis. Arch. Dis. Child., 106(8) : 745-752.
Fuchs A,Bielicki J,Mathur S,Sharland M and Van Den Anker JN .2018 .Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children. Paediatr Int. Child. H., 38 : S3-S15.
Garrido F,Allegaert K,Arribas C,Villamor E,Raffaeli G,Paniagua M,Cavallaro G,Group EAS G .2021 .Variations in antibiotic use and sepsis management in neonatal intensive care units: A European survey. Antibiotics, 10(9) : 1046.
Glaser MA,Hughes LM,Jnah A,Newberry D A .2021 .Neonatal sepsis: A review of pathophysiology and current management strategies. Adv. Neonatal Care, 21(1) : 49-60.
Hayes R,Hartnett J,Semova G,Murray C,Murphy K,Carroll L,Plapp H,Hession L,O'Toole J and McCollum D .2023 .Neonatal sepsis definitions from randomised clinical trials. Pediatr. Res., 93(5) : 1141-1148.
Hile GB,Musick KL,Dugan AJ,Bailey AM,Howington G .2020 .Occurrence of hyperbilirubinemia in neonates given a short-term course of ceftriaxone versus cefotaxime for sepsis. J. Pediatr Pharmacol, 26(1) : 99-103.
Kim F,Polin RA,Hooven TA .2020 .Neonatal sepsis. BMJ, 371 : m3672.
Korang SK,Safi S,Gluud C,Lausten-Thomsen U,Jakobsen JC .2019 .Antibiotic regimens for neonatal sepsis - A protocol for a systematic review with metaanalysis. Systematic Reviews, 8(1) : 306.
Korang S K S,Nava C,Gordon A,Gupta M,Greisen G,Lausten-Thomsen U,Jakobsen JC .2021 .Antibiotic regimens for early-onset neonatal sepsis. Cochrane DB Syst. Rev., : 13837.
Li T,Dong G,Zhang M,Hu Z,Xie Y,Wang B,Xu B Y .2020 .Association of neutrophil-lymphocyte ratio and the presence of neonatal sepsis. J. Immunol. Res., : 7650713.
Longardt A C,Piening B,von Weizsacker K,Dame C,Bührer C,Garten L C .2020 .Screening for thirdgeneration cephalosporin-resistant bacteria reduces the incidence on late-onset sepsis and antibiotic use in neonates. , 232(04) : 203-209.
Luo J,Chen C,Li Q C .2020 .White blood cell counting at point-of-care testing: A review. Electrophoresis, 41 : 1450-1468.
Mariani M,Parodi A,Minghetti D,Ramenghi LA,Palmero C,Ugolotti E,Medici C,Saffioti C,Castagnola E .2022 .Early and late onset neonatal sepsis: Epidemiology and effectiveness of empirical antibacterial therapy in a III level neonatal intensive care unit. Antibiotics, 11(2) : 284.
Mukhopadhyay S,Wade KC,Puopolo KM .2019 .Drugs for the prevention and treatment of sepsis in the newborn. Clin. perinatol., 46(2) : 327.
Nyenga AM,Mukuku O,Wembonyama SO .2021 .Neonatal sepsis: A review of the literature. Theory Clinical Practice in Pediatrics, 3 : 94-101.
Ogundare E,Akintayo A,Aladekomo T,Adeyemi L,Ogunlesi T,Oyelami O .2019 .Presentation and outcomes of early and late onset neonatal sepsis in a Nigerian Hospital. , 19(3) : 2390-2399.
Popescu CR,Cavanagh MM,Tembo B,Chiume M,Lufesi N,Goldfarb DM,Kissoon N,Lavoie PM .2020 .Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention. Expert Rev. Anti-infe, 18(5) : 443-452.
Procianoy RS,Silveira RC .2020 .The challenges of neonatal sepsis management. J. Pediat-Brazil, 96(suppl 1) : 80-86.
Qian C,Zhou M,Cheng F,Lin X,Gong Y,Xie X,Li P,Li Z,Zhang P .2020 .Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays. Clin. Chem. Lab Med, 58(9) : 1601-1607.
Rallis D,Giapros V,Serbis A,Kosmeri C,Baltogianni M C .2023 .Fighting antimicrobial resistance in neonatal intensive care units: rational use of antibiotics in neonatal sepsis. Antibiotics, 12(3) : 508.
Rohatgi S,Dewan P,Faridi MMA,Kumar A,Malhotra R K and Batra P A .2017 .Seven versus 10 days antibiotic therapy for culture‐proven neonatal sepsis: A randomised controlled trial. J. Paediatr Child, 53(6) : 556-562.
Shane AL,Sánchez PJ,Stoll BJ .2017 .Neonatal sepsis. The Lancet, 390(10104) : 1770-1780.
Shang Z,Wu Y,Lv D,Zhang W,Liu W,Van den Anker J,Xu Y,Zhao W .2022 .Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation. Front Pharmacol, 13 : 916253.
Shrivastava P,Gothalwal R,Gandhi P .2023 .Therapeutic strategies to ameliorate antibiotic resistance and host-inflammation response in sepsis: An innovative approach. Curr. Clin. Microbiol, 10(3) : 85-98.
Taneri PE,Biesty L,Kirkham JJ,Molloy EJ,Polin RA,Branagan A,Kawaza K,Daly M,Wynn J L and Bonnard LN .2025 .Proposed core outcomes after neonatal sepsis: A consensus statement. JAMA Netw Open, 8(2) : e2461554-e2461554.
Weissman SJ,Stoll B .2021 .Ampicillin and gentamicin in infants with suspected sepsis: Long live amp and gent-but for how long? JAMA pediatrics. , 175(2) : 131-132.
Yuan S,Zheng N,Zheng W,Jiang Q,Qiao B,Jing H,Li Y,Qi X,Cao W,Song S W .2021 .Analytical evaluation of Reebio procalcitonin latex-enhanced immunoturbidimetric assay on the HITACHI Labospect 008AS. Clin. Chem. Lab Med, 59(1) : e23-e26.
Zhang F .2020 .Efficacy of cefotaxime combined with gamma globulins on C-reactive protein and procalcitonin in neonatal sepsis. Cell Mol. Biol, 66(2) : 172-176.
Zwiri AM,Ahmad WMAW,Asif JA,Phaik KS,Husein A,Kassim NK,Ab-Ghani Z .2022 .A randomized controlled trial evaluating the levels of the biomarkers hs-CRP, IL-6 and IL-8 in patients with temporomandibular disorder treated with LLLT, traditional conservative treatment and a combination of both. Int. J. Environ. Res. Public Health, 19(15) : 8987.